GenEdit and Editas announce a worldwide, exclusive license and collaboration to enable safer and more effective delivery of CRISPR-based therapeutics.
“TenX has invested in Clarity, a three-year-old company that makes air-pollution monitoring devices which provide hyper-localised and real-time air-quality readings in metropolitan areas. Its…
